Tasly Pharmaceutical Investor

Tasly Pharmaceutical is a company that provides global market services with tech systems in the GMP. Tasly is pioneering the most aggressive paradigm shift in modern medicine: scientifically proving that the 5,000-year old medical practice of Modern Traditional Chinese Medicine (mTCM) – healing the body with pure, natural herbs, is as effective as treating it with chemical and synthetic drug compounds. This will fulfill an unmet clinical need for healthcare providers and patients alike by being able to treat serious diseases with chemical-free products, which could be a game changer in modern medicine. It offers herbal and chemical medicines, health products, pharmaceutical substances and APIs, herbal extracts, concentrated herbal granules, and tea series products.The company also provides cosmetic series products, including moisture lotions, moisture creams, eye creams, and face washing foams; daily hygiene products, such as sanitary and carefree pads, honey-propolis soaps, and pollen soaps; and medical equipment, which include massage tappers, massage cushions, and circulation machines. It also exports its products to approximately 23 countries in the United States, Europe, Africa, rest of Asia, and Russia. Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 and is based in Tianjin, China.

Invests into

Technology: N/A
Industry: AgeTech
Headquarters: Tianjin, Guangdong, China
Founded Date: 1994
Employees Number: 10001+
Funding Status: IPO
Investor Type: undisclosed
Investment Stage: Undisclosed
Number Of Exits: 1

Visit Website
Register and Claim Ownership